A quick Wikipedia read suggests he got quarter of the award for the AI bit and has no background in bio-chemistry. His partner has the chemistry background. The biggest chunk of that prize went to David Baker, who did the breakthrough work without AI. Fair play to them all. AlphaFold could be a useful tool. He's not got a background in cancer research, though.
As you know loads about him and have definitely not just Googled him or asked Claude for a name, has he himself ever said that you should only invest in AI for cancer research and give up on all the other technologies, or (more likely) that AlphaFold is a tool that can work alongside other research and technology to speed up progress in such areas?
Apologies to him for assuming you mentioned him because he had made the same claim as you, rather than it being another diversion away from the question you still haven't answered.
YOUR QUESTION
What is your reason for believing AI is a better investment in curing cancer than Moderna's (or other medical technology), to the point you'd bet the house on that single technology alone, no matter how much promise other technologies have shown in the last few years.
ANSWER THIS BIT